Henry Schein Inc
NASDAQ:HSIC
Intrinsic Value
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. [ Read More ]
The intrinsic value of one HSIC stock under the Base Case scenario is 102.4 USD. Compared to the current market price of 69.88 USD, Henry Schein Inc is Undervalued by 32%.
Valuation Backtest
Henry Schein Inc
Run backtest to discover the historical profit from buying and selling HSIC stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Henry Schein Inc
Current Assets | 4.5B |
Cash & Short-Term Investments | 171m |
Receivables | 1.9B |
Other Current Assets | 2.5B |
Non-Current Assets | 6.1B |
Long-Term Investments | 471m |
PP&E | 823m |
Intangibles | 4.8B |
Current Liabilities | 2.7B |
Accounts Payable | 1B |
Accrued Liabilities | 1.1B |
Short-Term Debt | 264m |
Other Current Liabilities | 287m |
Non-Current Liabilities | 4.2B |
Long-Term Debt | 1.9B |
Other Non-Current Liabilities | 2.3B |
Earnings Waterfall
Henry Schein Inc
Revenue
|
12.3B
USD
|
Cost of Revenue
|
-8.5B
USD
|
Gross Profit
|
3.9B
USD
|
Operating Expenses
|
-3.1B
USD
|
Operating Income
|
717m
USD
|
Other Expenses
|
-301m
USD
|
Net Income
|
416m
USD
|
Free Cash Flow Analysis
Henry Schein Inc
What is Free Cash Flow?
HSIC Profitability Score
Profitability Due Diligence
Henry Schein Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Henry Schein Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
HSIC Solvency Score
Solvency Due Diligence
Henry Schein Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Score
Henry Schein Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HSIC Price Targets Summary
Henry Schein Inc
According to Wall Street analysts, the average 1-year price target for HSIC is 81.51 USD with a low forecast of 65.65 USD and a high forecast of 94.5 USD.
Ownership
HSIC Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
HSIC Price
Henry Schein Inc
Average Annual Return | 6.86% |
Standard Deviation of Annual Returns | 7.63% |
Max Drawdown | -41% |
Market Capitalization | 9B USD |
Shares Outstanding | 130 743 875 |
Percentage of Shares Shorted | 4.93% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. The company is headquartered in Melville, New York and currently employs 21,600 full-time employees. The Company’s segments include Health care distribution and Technology and value-added services. The Health care distribution segment distributes consumable products, laboratory products, equipment repair services, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. Its global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions, medical practitioners and ambulatory surgery centers. The Technology and value-added services segments provides software, technology and other value-added services to health care practitioners. The company also offers practice management software systems for dental and medical practitioners. The firm's value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services.
Contact
IPO
Employees
Officers
The intrinsic value of one HSIC stock under the Base Case scenario is 102.4 USD.
Compared to the current market price of 69.88 USD, Henry Schein Inc is Undervalued by 32%.